The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A.
Dedieu
S
S
Inserm, U920, Talence, F-33400, France.
Canron
X
X
Rezvani
H R
HR
Bouchecareilh
M
M
Mazurier
F
F
Sinisi
R
R
Zanda
M
M
Moenner
M
M
Bikfalvi
A
A
North
S
S